Home / What is MOTS-c?
What is MOTS-c? A simple, honest beginner’s guide
Prepared by: Research Desk. Sources are linked for verification.
Contents
Status: Investigational. MOTS-c is not an FDA-approved drug, and it’s banned in WADA-tested sport. See our legal status page.
You may have seen MOTS-c described online as “exercise in a bottle” or a “longevity peptide”. It’s a genuinely fascinating discovery. It’s also very new, and most of what we know comes from mice. This guide explains it step by step, without jargon. It’s honest about what we know and what we don’t.
01
Step 1: First, a quick refresher on mitochondria
Mitochondria are tiny structures inside your cells, often called the cell’s “power plants”. They turn food and oxygen into usable energy.
Here’s the unusual part. Mitochondria have their own small set of DNA, separate from the main DNA in the cell’s nucleus. For a long time, scientists thought mitochondrial DNA only held instructions for a handful of energy-making parts. Then they started finding hidden instructions for small messenger molecules.
02
Step 2: So what is MOTS-c?
MOTS-c is one of those hidden messages. It’s a peptide, a short chain of amino acids. It’s just 16 amino acids long, and it’s made from instructions found in a part of mitochondrial DNA called the 12S rRNA gene [1]. Its name is short for “mitochondrial open reading frame of the 12S rRNA-c”.
MOTS-c belongs to a small family called mitochondrial-derived peptides (MDPs), which also includes humanin [1][2].
Scientists at the University of Southern California first described MOTS-c in 2015 [1].
03
Step 3: What does MOTS-c seem to do? (Mostly mouse research)
Muscle glucose handling (mouse research)
In the 2015 discovery study, MOTS-c’s main target appeared to be skeletal muscle. Inside cells, it activated an energy-sensing switch called AMPK [1]. AMPK is the same switch that exercise turns on, which is where the “exercise mimic” idea comes from.
In mice, researchers observed that MOTS-c administration prevented insulin resistance, both age-related and caused by a high-fat diet. It also prevented diet-induced obesity [1].
It can travel to the cell’s “control centre”
A 2018 study found that when cells were under metabolic stress, such as a shortage of sugar, MOTS-c moved into the nucleus. There it helped switch on genes involved in stress protection, including antioxidant genes [3]. This suggested the mitochondria and nucleus “talk” to each other more than scientists realised.
It improved physical performance in mice of all ages
In a 2021 study, MOTS-c improved physical performance in young, middle-aged and old mice [4]. When administration started late in life (at about 23.5 months, which is elderly for a mouse), it increased physical capacity and healthspan in the mice [4].
04
Step 4: What do we know in humans?
This is the most important section, so let’s go slowly.
Exercise and natural MOTS-c levels
The same 2021 study found that in humans, exercise increases MOTS-c in skeletal muscle and in the bloodstream [4]. The body makes it naturally, and levels rose with exercise in that study.
A 2026 systematic review looked at nine studies of exercise and mitochondrial-derived peptides. Most found a trend toward higher levels after exercise. The authors cautioned that there were few studies and they varied a lot, and that human evidence is limited [2].
A 2026 study compared adults with cerebral palsy and typically developing people. It measured MOTS-c and related peptides in blood at rest and after exercise. Resting levels were similar between groups, and changes after a single exercise session were “no or only modest” [5]. So the exercise response may depend on the type of exercise, the timing and the person.
MOTS-c administration in humans: no published results yet
We could not find any published, peer-reviewed randomized trial results of MOTS-c administered to people. A phase 2a trial testing MOTS-c for insulin sensitivity in adults with prediabetes and overweight or obesity is now recruiting in China [6]. Until results like these are published, claims about what MOTS-c does in people are educated guesses.
05
Step 5: MOTS-c claims: a simple scorecard
Claim
What’s the evidence?
Our plain-English verdict
Better blood sugar control
Mice [1]; human phase 2a trial underway [6]
Promising in mice; unproven in people
Prevents weight gain
Mice on high-fat diets [1]
Unproven in people
Better physical performance
Mice of all ages [4]
Unproven in people
“Exercise in a bottle”
It activates AMPK like exercise does [1]
Misleading. Exercise does much more than one pathway
Longer life
Healthspan improved in old mice [4]
Unproven in people
06
Step 6: MOTS-c side effects
The honest answer: we don’t know.
No published human administration trials have reported on safety yet.
Products sold online as “research peptides” aren’t checked for purity, sterility or strength. That adds risks that have nothing to do with MOTS-c itself.
Long-term effects of raising MOTS-c above natural levels are unknown.
If someone tells you MOTS-c has “no side effects”, ask how they know. The research needed to say that hasn’t been done.
07
Step 7: Mitochondrial peptides, the bigger picture
MOTS-c is part of an exciting new area of science. Mitochondria aren’t just power plants: they seem to send out messages that help coordinate metabolism across the body [1][3][4]. Researchers are studying other mitochondrial-derived peptides too, including humanin [2][5]. This field may lead to new medicines one day. “One day” is the key phrase.
08
Step 8: Legal status in one paragraph
MOTS-c is not an FDA-approved drug. FDA’s Pharmacy Compounding Advisory Committee discussed it in July 2026 for possible use by compounding pharmacies, for obesity and osteoporosis. The World Anti-Doping Agency prohibits it at all times. Full details, with sources, are on our legal status page.
09
Step 9: What the exercise research shows
Researchers have reported that exercise raises the body’s own MOTS-c [2][4], although the size of the response varied between studies [2][5].
Frequently asked questions
Is MOTS-c a steroid?
No. It’s a small peptide, not a steroid hormone.
Is MOTS-c natural?
The body makes it naturally. Products sold online are synthetic copies.
Is MOTS-c the same as NAD+?
No. They’re different molecules. Both are linked to metabolism and aging research.
Has MOTS-c been tested for body weight in people?
Not in published trials. It prevented diet-induced weight gain in mice [1].
How to read MOTS-c news without getting misled
New MOTS-c headlines appear often. Here’s a simple four-question check you can use on any article or video:
Was it mice or people? Most findings so far are from mice [1][4]. If a headline claims a metabolic effect but the study was in mice, the accurate headline adds “in mice”.
Was MOTS-c administered, or measured naturally? Studies that measure the body’s own MOTS-c after exercise [4][5] tell us something different from studies that administer MOTS-c.
Was there a comparison group? Good studies compare against placebo or a control group, like the phase 2a trial now recruiting [6].
Is someone selling something? Be extra careful when the source of the claim also sells the product.
Mini glossary
Peptide: a short chain of amino acids, the building blocks of proteins.
Mitochondria: the cell’s energy-producing structures, with their own small set of DNA.
Mitochondrial-derived peptide (MDP): a peptide made from instructions in mitochondrial DNA. MOTS-c and humanin are examples [1][2].
AMPK: an energy-sensing switch inside cells that exercise turns on. MOTS-c activated it in the discovery study [1].
Insulin resistance: when the body’s cells respond poorly to insulin, making blood sugar harder to control.
Investigational: being tested in research, not approved as a medicine.
Phase 2a trial: an early-to-middle-stage trial that tests whether an investigational drug shows signs of working, and gathers more safety information, in a modest number of people.
Placebo: a dummy substance used for comparison, so researchers can tell real effects from chance or expectation.
A note on who did the research
Much of the foundational MOTS-c research comes from one university group, and some of its scientists have disclosed consulting roles and shares in a company developing mitochondrial peptide medicines [4]. That’s common in biomedical research and doesn’t make the findings wrong. It’s one more reason to wait for independent clinical trials.
Last updated: 18 October 2026.
Not medical advice. This page reports published research and regulatory records for information only.